Diana Maria Lopategui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Diana Maria Lopategui has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Hemendra Navinchandra Shah
Desai Sethi Urology Institute University of Miami Miller School of Medicine Miami Florida USA
8 shared publications - Joao Gabriel Porto
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, FL, USA
8 shared publications - Ansh Bhatia
Department of Interventional Radiology, University of Miami, Miller School of Medicine, Miami, USA
6 shared publications Robert Marcovich
Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, USA
6 shared publicationsAnsh Bhatia
Seth GS Medical College and KEM Hospital, Mumbai, India
3 shared publications- Ruben Blachman-Braun
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
3 shared publications
Latest Publications
- Open Access
- 24 January 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-37
Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century
Purpose: To compare outcomes of transurethral resection of the prostate (TURP) across different regions worldwide over the past two decades. Methods: A systematic review and meta-analysis of randomized clinical trials indexed to PubMed that assessed TURP. A total of 102 studies with 8,454 patients were included and grouped by continents: Europe, Asia, Africa, and Others (North America, South America, and Australia). International Prostate Symptom Score (IPSS), peak flow (Qmax), postvoid residual urine (PVR), PSA levels, prostate volume, and Sexual Health Inventory for Men scores (at 3, 12, and 36 months) were assessed, along with postoperative complications. Heterogeneity across studies was classified as low (I 2 < 25%), moderate (I 2 = 25–75%), or high (I 2 > 75%). Results: TURP consistently exhibited significant enhancements in IPSS, Qmax, and PVR across various regions. Notably, PVR demonstrated high heterogeneity (I²=100%). TURP presented low complication rates with TURP syndrome (2%), bleeding (8%), and blood transfusion (6%). However, significant heterogeneity was observed, particularly for clot evacuation (I 2 = 87%), irritative symptoms (I 2 = 96%), and incontinence (I 2 = 84%). The retreatment rates at 1 and 3 years were 5% and 7%, respectively, with significant differences across regions. Conclusion: Global outcomes of TURP lack a discernible trend. The substantial heterogeneity observed among continents suggests a lack of standardization. Nevertheless, uniform symptomatic improvements among patients still support TURP as the gold-standard surgical treatment for benign prostatic hyperplasia, despite variations in its results worldwide.
- 24 January 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-37
Open AccessTransurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century
Purpose: To compare outcomes of transurethral resection of the prostate (TURP) across different regions worldwide over the past two decades. Methods: A systematic review and meta-analysis of randomized clinical trials indexed to PubMed that assessed TURP. A total of 102 studies with 8,454 patients were included and grouped by continents: Europe, Asia, Africa, and Others (North America, South America, and Australia). International Prostate Symptom Score (IPSS), peak flow (Qmax), postvoid residual urine (PVR), PSA levels, prostate volume, and Sexual Health Inventory for Men scores (at 3, 12, and 36 months) were assessed, along with postoperative complications. Heterogeneity across studies was classified as low (I 2 < 25%), moderate (I 2 = 25–75%), or high (I 2 > 75%). Results: TURP consistently exhibited significant enhancements in IPSS, Qmax, and PVR across various regions. Notably, PVR demonstrated high heterogeneity (I²=100%). TURP presented low complication rates with TURP syndrome (2%), bleeding (8%), and blood transfusion (6%). However, significant heterogeneity was observed, particularly for clot evacuation (I 2 = 87%), irritative symptoms (I 2 = 96%), and incontinence (I 2 = 84%). The retreatment rates at 1 and 3 years were 5% and 7%, respectively, with significant differences across regions. Conclusion: Global outcomes of TURP lack a discernible trend. The substantial heterogeneity observed among continents suggests a lack of standardization. Nevertheless, uniform symptomatic improvements among patients still support TURP as the gold-standard surgical treatment for benign prostatic hyperplasia, despite variations in its results worldwide.
- 8 January 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-2
Resection of sigmoid cancer with bladder invasion using laparoscopic combined with a cystoscopic holmium laser: comment
- 8 January 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-2
Resection of sigmoid cancer with bladder invasion using laparoscopic combined with a cystoscopic holmium laser: comment
- Open Access
- 15 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-37
Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials
Purpose: The goal of this systematic review is to assess the temporal changes in outcomes and complications of transurethral resection of the prostate (TURP) from 2000 to 2022. Methods: We conducted a systematic review and meta-analysis of 103 randomized clinical trials from PubMed on TURP, involving 8521 patients. Studies were grouped by years: 2000–2004, 2005–2009, 2010–2014, and 2015–2022. We assessed International Prostate Symptom Score (IPSS), Peak Flow (Qmax), Post-void residue of urine (PVR), and post-operative complications. Heterogeneity was ranked as low (I2 < 25%), moderate (I2 = 25–75%), or high (I2 > 75%). Results: TURP significantly improved IPSS, Qmax, and PVR, with the most recent studies showing superior results in IPSS and Qmax after 3 years compared to 2000–2004 studies. Heterogeneity in PVR was high (I2 = 100%). No negative impact on erectile function was observed. Complication rates included TURP syndrome (2%), bleeding (8%), and blood transfusion (6%), but elevated heterogeneity with difference between the groups was seen in clot evacuation (I2 = 83%) and urinary tract infections (I2 = 82%). Other complications were urinary retention (4%), incontinence (8%), urethral stricture (3%), bladder neck stenosis (2%). Conclusion: In the last 20 years there has not been a clear trend in the results of TURP. The found heterogeneity may indicate a lack of standardization in TURP procedures. However, symptomatic improvement among patients is uniform, which supports this procedure as a historical benchmark surgical treatment for BPH.
- 15 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-37
Open AccessEvaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials
Purpose: The goal of this systematic review is to assess the temporal changes in outcomes and complications of transurethral resection of the prostate (TURP) from 2000 to 2022. Methods: We conducted a systematic review and meta-analysis of 103 randomized clinical trials from PubMed on TURP, involving 8521 patients. Studies were grouped by years: 2000–2004, 2005–2009, 2010–2014, and 2015–2022. We assessed International Prostate Symptom Score (IPSS), Peak Flow (Qmax), Post-void residue of urine (PVR), and post-operative complications. Heterogeneity was ranked as low (I2 < 25%), moderate (I2 = 25–75%), or high (I2 > 75%). Results: TURP significantly improved IPSS, Qmax, and PVR, with the most recent studies showing superior results in IPSS and Qmax after 3 years compared to 2000–2004 studies. Heterogeneity in PVR was high (I2 = 100%). No negative impact on erectile function was observed. Complication rates included TURP syndrome (2%), bleeding (8%), and blood transfusion (6%), but elevated heterogeneity with difference between the groups was seen in clot evacuation (I2 = 83%) and urinary tract infections (I2 = 82%). Other complications were urinary retention (4%), incontinence (8%), urethral stricture (3%), bladder neck stenosis (2%). Conclusion: In the last 20 years there has not been a clear trend in the results of TURP. The found heterogeneity may indicate a lack of standardization in TURP procedures. However, symptomatic improvement among patients is uniform, which supports this procedure as a historical benchmark surgical treatment for BPH.
- 5 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-13
Open simple prostatectomy in the last three decades: results of a meta-analysis
Purpose Open simple prostatectomy (OSP) has been a cornerstone in treating large prostate volumes (> 80 ml) in benign prostatic hyperplasia (BPH). With evolving minimally invasive procedures like minimally invasive simple prostatectomy (MISP) and laser enucleation, the role of OSP needs contemporary evaluation. This way, we assessed the efficacy and safety of OSP to understand its current standing in the treatment of BPH, especially in comparison with newer surgical modalities. Methods A comprehensive search of MEDLINE, Cochrane and EMBASE was conducted to include randomized controlled trials (RCTs) comparing OSP with other treatments for BPH from 1993 to 2023. A total of 10 RCTs were included in the meta-analysis. Data on various outcomes including IPSS, Qmax, PVR, quality of life, perioperative factors, and postoperative complications were analysed. Results Our meta-analysis, covering 557 patients, confirms OSP’s significant improvement in voiding symptoms and objective voiding metrics. However, it also reveals a higher incidence of postoperative complications, such as bleeding and transfusion requirements. The study found moderate to high heterogeneity in perioperative outcomes, indicating variations in surgical techniques and postoperative care. OSP remains a reliable option with an easily accessible and effective approach for managing large prostates, despite advancements in minimally invasive surgeries. Conclusion OSP continues to be a relevant surgical option for BPH in large prostates, offering significant symptom relief. However, the associated higher morbidity warrants careful patient selection and highlights the need for continued research into optimizing surgical techniques and improving outcomes.
- 5 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-13
Open simple prostatectomy in the last three decades: results of a meta-analysis
Purpose Open simple prostatectomy (OSP) has been a cornerstone in treating large prostate volumes (> 80 ml) in benign prostatic hyperplasia (BPH). With evolving minimally invasive procedures like minimally invasive simple prostatectomy (MISP) and laser enucleation, the role of OSP needs contemporary evaluation. This way, we assessed the efficacy and safety of OSP to understand its current standing in the treatment of BPH, especially in comparison with newer surgical modalities. Methods A comprehensive search of MEDLINE, Cochrane and EMBASE was conducted to include randomized controlled trials (RCTs) comparing OSP with other treatments for BPH from 1993 to 2023. A total of 10 RCTs were included in the meta-analysis. Data on various outcomes including IPSS, Qmax, PVR, quality of life, perioperative factors, and postoperative complications were analysed. Results Our meta-analysis, covering 557 patients, confirms OSP’s significant improvement in voiding symptoms and objective voiding metrics. However, it also reveals a higher incidence of postoperative complications, such as bleeding and transfusion requirements. The study found moderate to high heterogeneity in perioperative outcomes, indicating variations in surgical techniques and postoperative care. OSP remains a reliable option with an easily accessible and effective approach for managing large prostates, despite advancements in minimally invasive surgeries. Conclusion OSP continues to be a relevant surgical option for BPH in large prostates, offering significant symptom relief. However, the associated higher morbidity warrants careful patient selection and highlights the need for continued research into optimizing surgical techniques and improving outcomes.
- Open Access
- 30 October 2024
- Published by Wiley in BJUI Compass
- Vol. 5 (12) , 1231-1245
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
Introduction: Water Jet Ablation Therapy (WJAT) and Holmium Laser Enucleation of the Prostate (HoLEP) represent two common surgical treatments for Benign Prostatic Hyperplasia (BPH). Despite their increasing use, there is no study between these two methods. We aim to evaluate their efficacy and safety through a network meta‐analysis (NMA), providing critical insights for clinical decision‐making in the management of moderate to severe lower urinary tract symptoms (LUTS) due to BPH.Methods: Pubmed, EMBASE and Cochrane Library were searched. Randomized controlled trials and prospective single‐arm studies comparing WJAT and HoLEP with TURP, reporting symptom scores, flow rates and adverse events. Data extraction and quality assessments were independently performed. Bayesian modelling in RStudio was used for statistical analysis, evaluating continuous outcomes through mean difference and categorical variables via risk ratios. Risk‐of‐Bias (RoB) and GRADE assessments were performed.Findings: Twenty‐three studies were included (WJAT‐11, HoLEP‐12). Most studies were at some or high risk of bias. At 12 months, the IPSS, Qol, PVR and Qmax improvements were 4.14 points (95% CI: ‐0.34 to 8.64, not‐significant [NS], GRADE‐rating: Low), 0.32‐points (95% CI:‐10.70 to 3.27, NS, GRADE‐rating: Low), 2.45 ml/s (95% CI: ‐1.85 to 7.05, NS, GRADE‐rating: Low), 63.10 ml (95% CI: 39.80 to 87.30, statistically‐significant [SS], GRADE‐rating: Moderate), respectively, all in favour of HoLEP. Haemoglobin‐loss was lower with HoLEP, 1.16 g/dl (95% CI: ‐2.56 to 0.54 mg/dl, NS, GRADE‐rating: Moderate) than WJAT. The risk of incontinence was higher with HoLEP; 4.48 (95% CI: 0.22 to 168.50, NS, GRADE‐rating: Very Low) than WJAT in single–arm analysis. The risk of blood transfusion was higher with WJAT (RR = 0.14; 95% CI: 0.00 to 4.21, NS, GRADE‐rating: Low) than HoLEP. Risk of Total Serious Adverse Events (Clavien‐Dindo grade>3) was higher with HoLEP (RR = 1.12, higher with HoLEP, 95% CI: 0.20 to 12.71, NS, GRADE‐rating: Low) than WJAT. Retreatment was lower with HoLEP (RR = 0.46, 95% CI: 0.02 to 10.54 GRADE‐rating: Low) than WJAT.Interpretation: Our study suggests that both HoLEP and WJAT are effective treatments for BPH, both with similar IPSS and QoL improvements. HoLEP excels in functional outcomes, particularly in improving Qmax and PVR. Conversely, WJAT, with its shorter operation time and hospital stays, presents a compelling alternative, particularly for outpatient settings.
- 30 October 2024
- Published by Wiley in BJUI Compass
- Vol. 5 (12) , 1231-1245
Open AccessComparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
Introduction: Water Jet Ablation Therapy (WJAT) and Holmium Laser Enucleation of the Prostate (HoLEP) represent two common surgical treatments for Benign Prostatic Hyperplasia (BPH). Despite their increasing use, there is no study between these two methods. We aim to evaluate their efficacy and safety through a network meta‐analysis (NMA), providing critical insights for clinical decision‐making in the management of moderate to severe lower urinary tract symptoms (LUTS) due to BPH.Methods: Pubmed, EMBASE and Cochrane Library were searched. Randomized controlled trials and prospective single‐arm studies comparing WJAT and HoLEP with TURP, reporting symptom scores, flow rates and adverse events. Data extraction and quality assessments were independently performed. Bayesian modelling in RStudio was used for statistical analysis, evaluating continuous outcomes through mean difference and categorical variables via risk ratios. Risk‐of‐Bias (RoB) and GRADE assessments were performed.Findings: Twenty‐three studies were included (WJAT‐11, HoLEP‐12). Most studies were at some or high risk of bias. At 12 months, the IPSS, Qol, PVR and Qmax improvements were 4.14 points (95% CI: ‐0.34 to 8.64, not‐significant [NS], GRADE‐rating: Low), 0.32‐points (95% CI:‐10.70 to 3.27, NS, GRADE‐rating: Low), 2.45 ml/s (95% CI: ‐1.85 to 7.05, NS, GRADE‐rating: Low), 63.10 ml (95% CI: 39.80 to 87.30, statistically‐significant [SS], GRADE‐rating: Moderate), respectively, all in favour of HoLEP. Haemoglobin‐loss was lower with HoLEP, 1.16 g/dl (95% CI: ‐2.56 to 0.54 mg/dl, NS, GRADE‐rating: Moderate) than WJAT. The risk of incontinence was higher with HoLEP; 4.48 (95% CI: 0.22 to 168.50, NS, GRADE‐rating: Very Low) than WJAT in single–arm analysis. The risk of blood transfusion was higher with WJAT (RR = 0.14; 95% CI: 0.00 to 4.21, NS, GRADE‐rating: Low) than HoLEP. Risk of Total Serious Adverse Events (Clavien‐Dindo grade>3) was higher with HoLEP (RR = 1.12, higher with HoLEP, 95% CI: 0.20 to 12.71, NS, GRADE‐rating: Low) than WJAT. Retreatment was lower with HoLEP (RR = 0.46, 95% CI: 0.02 to 10.54 GRADE‐rating: Low) than WJAT.Interpretation: Our study suggests that both HoLEP and WJAT are effective treatments for BPH, both with similar IPSS and QoL improvements. HoLEP excels in functional outcomes, particularly in improving Qmax and PVR. Conversely, WJAT, with its shorter operation time and hospital stays, presents a compelling alternative, particularly for outpatient settings.
- 1 August 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (8) , 852-864
Application of Natural Language Processing in Electronic Health Record Data Extraction for Navigating Prostate Cancer Care: A Narrative Review
Introduction: Natural language processing (NLP)-based data extraction from electronic health records (EHRs) holds significant potential to simplify clinical management and aid research. This review aims to evaluate the current landscape of NLP-based data extraction in prostate cancer (PCa) management. Materials and Methods: We conducted a literature search of PubMed and Google Scholar databases using the keywords: “Natural Language Processing,” “Prostate Cancer,” “data extraction,” and “EHR” with variations of each. No language or time limits were imposed. All results were collected in a standardized manner, including country of origin, sample size, algorithm, objective of outcome, and model performance. The precision, recall, and the F1 score of studies were collected as a metric of model performance. Results: Of the 14 studies included in the review, 2 articles focused on documenting digital rectal examinations, 1 on identifying and quantifying pain secondary to PCa, 8 on extracting staging/grading information from clinical reports, with an emphasis on TNM-classification, risk stratification, and identifying metastasis, 2 articles focused on patient-centered post-treatment outcomes such as incontinence, erectile, and bowel dysfunction, and 1 on loneliness/social isolation following PCa diagnosis. All models showed moderate to high data annotation/extraction accuracy compared with the gold standard method of manual data extraction by chart review. Despite their potential, NLPs face challenges in handling ambiguous, institution-specific language and context nuances, leading to occasional inaccuracies in clinical data interpretation. Conclusion: NLP-based data extraction has effectively extracted various outcomes from PCa patients' EHRs. It holds the potential for automating outcome monitoring and data collection, resulting in time and labor savings.
- 1 August 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (8) , 852-864
Application of Natural Language Processing in Electronic Health Record Data Extraction for Navigating Prostate Cancer Care: A Narrative Review
Introduction: Natural language processing (NLP)-based data extraction from electronic health records (EHRs) holds significant potential to simplify clinical management and aid research. This review aims to evaluate the current landscape of NLP-based data extraction in prostate cancer (PCa) management. Materials and Methods: We conducted a literature search of PubMed and Google Scholar databases using the keywords: “Natural Language Processing,” “Prostate Cancer,” “data extraction,” and “EHR” with variations of each. No language or time limits were imposed. All results were collected in a standardized manner, including country of origin, sample size, algorithm, objective of outcome, and model performance. The precision, recall, and the F1 score of studies were collected as a metric of model performance. Results: Of the 14 studies included in the review, 2 articles focused on documenting digital rectal examinations, 1 on identifying and quantifying pain secondary to PCa, 8 on extracting staging/grading information from clinical reports, with an emphasis on TNM-classification, risk stratification, and identifying metastasis, 2 articles focused on patient-centered post-treatment outcomes such as incontinence, erectile, and bowel dysfunction, and 1 on loneliness/social isolation following PCa diagnosis. All models showed moderate to high data annotation/extraction accuracy compared with the gold standard method of manual data extraction by chart review. Despite their potential, NLPs face challenges in handling ambiguous, institution-specific language and context nuances, leading to occasional inaccuracies in clinical data interpretation. Conclusion: NLP-based data extraction has effectively extracted various outcomes from PCa patients' EHRs. It holds the potential for automating outcome monitoring and data collection, resulting in time and labor savings.
- 25 February 2024
- Published by Wiley in BJU International
- Vol. 133 (5) , 628
Letter Re: ‘Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial’
- 25 February 2024
- Published by Wiley in BJU International
- Vol. 133 (5) , 628
Letter Re: ‘Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial’
- 30 January 2024
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 21 (2) , 192-194
A novel technique for contained aspiration and irrigation of priapism
Background: Ischemic priapism is a urological emergency requiring prompt corporal aspiration and irrigation, with risk of blood spillage that can place a significant biological hazard to the urologist and rest of emergency room staff. Aim: The study sought to develop and validate a method for contained corporal aspiration that minimizes exposure to sharps and occupational hazards. Methods: We used one large bore needle connected to a vacuum aspiration device and blood draw tubes for corporal aspiration and irrigation of ischemic priapism. Outcomes: Feasibility of this method was assessed in 18 consecutive patients presenting to the emergency room with ischemic priapism. Clinical characteristics, resolution of priapism, and need for further interventions were documented. Results: A total of 18 patients were treated using this technique. The mean time from onset to presentation was 12 hours. The etiology in all patients was recreational intracavernosal drug abuse, and 72% were HIV positive. Priapism completely resolved in all 18 patients. No patients required shunt procedures or further interventions to achieve detumescence. Clinical Implications: This system can be used for safe management of ischemic priapism in any clinical scenario but is particularly beneficial to minimize exposure risk in the setting of increased risk of blood-borne infections. Strengths and Limitations: This initial trial shows that this technique is safe and effective for cavernosal aspiration of ischemic priapism. Larger trials are required to validate this method. Conclusion: Contained aspiration and irrigation of priapism can be used for effective management of ischemic priapism while minimizing health risks to urologists and emergency room staff.
- 30 January 2024
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 21 (2) , 192-194
A novel technique for contained aspiration and irrigation of priapism
Background: Ischemic priapism is a urological emergency requiring prompt corporal aspiration and irrigation, with risk of blood spillage that can place a significant biological hazard to the urologist and rest of emergency room staff. Aim: The study sought to develop and validate a method for contained corporal aspiration that minimizes exposure to sharps and occupational hazards. Methods: We used one large bore needle connected to a vacuum aspiration device and blood draw tubes for corporal aspiration and irrigation of ischemic priapism. Outcomes: Feasibility of this method was assessed in 18 consecutive patients presenting to the emergency room with ischemic priapism. Clinical characteristics, resolution of priapism, and need for further interventions were documented. Results: A total of 18 patients were treated using this technique. The mean time from onset to presentation was 12 hours. The etiology in all patients was recreational intracavernosal drug abuse, and 72% were HIV positive. Priapism completely resolved in all 18 patients. No patients required shunt procedures or further interventions to achieve detumescence. Clinical Implications: This system can be used for safe management of ischemic priapism in any clinical scenario but is particularly beneficial to minimize exposure risk in the setting of increased risk of blood-borne infections. Strengths and Limitations: This initial trial shows that this technique is safe and effective for cavernosal aspiration of ischemic priapism. Larger trials are required to validate this method. Conclusion: Contained aspiration and irrigation of priapism can be used for effective management of ischemic priapism while minimizing health risks to urologists and emergency room staff.
- Open Access
- 1 January 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 37, 100820
Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial
- 1 January 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 37, 100820
Open AccessDecoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial